Quality assurance in drug-related treatment in the European Union
Shared by: wvd19763
Quality assurance in drug-related treatment in the European Union and Norway Ulrik Solberg, Lisbon, 28th of November 2003 What is quality assurance? • A tentative definition: ’A systematic attempt to monitor, keep track or improve the quality of services provided at treatment centres’ • Hence, not only success rates but also monitoring and surveying • Not linked only to outcomes but also to processes Examples of quality assurance • Formal requirements (for treatment services) • Standards (for treatment) • Training (of staff) • Monitoring (of clients and outcomes) • Evaluation and research (of retention rates, outcomes, satisfaction, discharge etc.) EU Action Plan on Drugs 2000-2004 Under strategy target 3: 126.96.36.199 Member States to define clear guidelines for the standards and goals of treatment services and to ensure the evidence based evaluation of the treatment according to those guidelines. Emphasis should be given to a scientific evaluation of different treatment strategies. National Reports on quality assurance • Generally little information provided • Big differences in ways of reporting • Wide oscillations in quality assurance mechanisms in place Other factors in comparing quality assurance • Organisation of drug-related treatment plus financing models of treatment vary • Difficulties with translations and accurate connotations – and all into English • Big chunk of soft and not easily comparable data • Unique national contexts EMCDDA web-publication • Summaries of National Report parts • National overviews according to ’examples of quality assurance’ • Generally, quality assurance mechanisms apply to both treatment and social reintegration • No comprehensive European overview nor cross- country comparisons EMCDDA web-publication • Quality assurance at three levels: 1. Centre itself, 2. Regional level, 3. National level (five examples of quality assurance applicable to all levels) • But quality assurance can also be; co-operation between services or referral • Intra or interinstitutional measure Improvement of data and comparability • Expert meeting in October 2002 on quality assurance • Participation from current and future Member States • Development of first draft of new data collection tool • Later decided to be a structured questionnaire – including part on quality assurance Enlargement and future • Increasingly structured and data collection • Standard table on drug-related treatment availability • Structured questionnaire – for more qualitative data • Testing in Member States from February 2004 • Implementation from 2005 Future perspectives • 80’s and 90’s witnessed substantial increase in availability of drug-related treatment • Future, focus on assuring quality of the drug- related treatment provided • Now, many initiatives planned or conceived • Future, implementation and consolidation of such plans.